Skip to main content
    U

    USANA Health Sciences Inc (USNA)

    Official site

    CONSUMER DEFENSIVE • PACKAGED FOODS • NYSE

    $15.46
    +0.51 (+3.41%)

    Market Cap: $282.14M

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    72%(28/39)
    Avg Surprise
    +13.26%

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$0.11
    Range$0.11 - $0.11
    1 analysts
    EPS RevisionsNo revisions (7d)
    0
    1
    30d
    EPS Estimate DriftChange to current
    90d ago$0.43-74.4%
    60d ago$0.110.0%
    30d ago$0.110.0%
    7d ago$0.110.0%
    Current$0.11
    Revenue Consensus
    $217M
    Range$217M - $217M
    1 analysts
    Period ending Dec 31, 2026
    EPS Consensus$-0.22
    Range$-0.22 - $-0.22
    1 analysts
    Revenue Consensus
    $216M
    Range$216M - $216M
    1 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$-0.22---
    Sep 26EST
    		-$0.11---
    Jun 26
    Reported Aug 4
    		$-0.07N/A-116.28%Miss-109.5%
    Mar 26
    Reported May 5
    		$0.61$0.44+38.64%Beat-16.4%
    Dec 25
    Reported Feb 17
    		$0.60$0.41+46.34%Beat-6.3%
    Sep 25
    Reported Oct 21
    		$-0.15$-0.15+0.00%Beat-126.8%
    Jun 25
    Reported Jul 22
    		$0.74$0.54+37.04%Beat+37.0%
    Mar 25
    Reported Apr 22
    		$0.73$0.70+4.29%Beat-15.1%
    Dec 24
    Reported Feb 25
    		$0.64$0.49+30.61%Beat-26.4%
    Sep 24
    Reported Oct 22
    		$0.56$0.49+14.29%Beat-5.1%
    Jun 24
    Reported Jul 23
    		$0.54$0.65-16.92%Miss-39.3%
    Mar 24
    Reported Apr 30
    		$0.86$0.69+24.64%Beat-9.5%
    Dec 23
    Reported Feb 6
    		$0.87$0.52+67.31%Beat+31.8%
    Sep 23
    Reported Oct 24
    		$0.59$0.64-7.81%Miss-24.4%
    Jun 23
    Reported Jul 25
    		$0.89$0.70+27.14%Beat-11.0%
    Mar 23
    Reported Apr 25
    		$0.95$0.77+23.38%Beat-17.4%
    Dec 22
    Reported Feb 7
    		$0.66$0.35+88.57%Beat-35.9%
    Sep 22
    Reported Oct 25
    		$0.78$0.89-12.36%Miss-42.6%
    Jun 22
    Reported Jul 26
    		$1.00$1.05-4.76%Miss-46.5%
    Mar 22
    Reported Apr 26
    		$1.15$1.14+0.88%Beat-20.7%
    Dec 21
    Reported Feb 8
    		$1.03$1.28-19.53%Miss-44.9%
    Sep 21
    Reported Oct 26
    		$1.36$1.35+0.74%Beat-5.6%
    Jun 21
    Reported Jul 27
    		$1.87$1.78+5.06%Beat+41.7%
    Mar 21
    Reported Apr 27
    		$1.45$1.57-7.64%Miss+17.9%
    Dec 20
    Reported Feb 9
    		$1.87$1.39+34.53%Beat+32.6%
    Sep 20
    Reported Oct 20
    		$1.44$1.29+11.63%Beat+32.1%
    Jun 20
    Reported Jul 21
    		$1.32$1.19+10.92%Beat+45.1%
    Mar 20
    Reported Apr 21
    		$1.23$0.57+115.79%Beat+21.8%
    Dec 19
    Reported Feb 4
    		$1.41$0.98+43.88%Beat+6.8%
    Sep 19
    Reported Oct 22
    		$1.09$0.87+25.29%Beat-12.1%
    Jun 19
    Reported Jul 23
    		$0.91$0.93-2.15%Miss-33.1%
    Mar 19
    Reported Apr 30
    		$1.01$0.99+2.02%Beat-15.1%
    Dec 18
    Reported Feb 5
    		$1.32$1.29+2.33%Beat+18.9%
    Sep 18
    Reported Oct 23
    		$1.24$1.10+12.73%Beat+21.6%
    Jun 18
    Reported Jul 24
    		$1.36$1.11+22.52%Beat+38.8%
    Mar 18
    Reported Apr 24
    		$1.19$1.05+13.33%Beat+38.4%
    Dec 17
    Reported Feb 6
    		$1.11$1.00+11.00%Beat+27.6%
    Sep 17
    Reported Oct 24
    		$1.02$0.91+12.09%Beat-
    Jun 17
    Reported Jul 25
    		$0.98$1.06-7.55%Miss-
    Mar 17
    Reported May 2
    		$0.86$0.92-6.52%Miss-
    Dec 16
    Reported Feb 7
    		$0.87$0.95-8.42%Miss-

    Key Metrics

    Valuation
    P/E Ratio15.62EV/EBITDA2.81x
    Price/FCF17.94xFCF Yield5.58%
    Profitability
    Profit Margin-2.43%Operating Margin4.09%
    ROE-5.06%ROICN/A
    Financial Health
    Debt/Equity0.00xInterest Coverage50.32x
    Current Ratio2.66xQuick Ratio1.84x
    Trading Statistics
    Beta0.68Avg Volume179.04K
    52-Week High$23.5952-Week Low$12.57

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$14.77
    SMA 20$14.63
    SMA 50$14.54
    SMA 200$18.45
    EMA 10$14.85
    EMA 20$14.77
    EMA 50$15.45
    EMA 200$18.47

    MACD

    Line: -0.01Signal: -0.14Hist: 0.12

    ADX

    ADX: 11.3+DI: 23.7-DI: 17.9

    Aroon & PSAR

    Aroon UpN/A
    Aroon Down48.0
    PSAR$14.35

    Bollinger Bands

    Upper Band$15.26
    Lower Band$13.99
    %B Position871%(Upper)
    Band Width1.15

    RSI (14-Day)

    Neutral
    59.2

    Momentum Oscillators

    Stoch %K75.1
    Stoch %D68.0
    Williams %R-11.2
    ROC (10d)5.2%
    Momentum0.76
    CCI (20d)223.9
    MFI (14d)62.4

    Volatility Measures

    ATR (14d)$0.59(3.8%)
    StdDev (20d)0.32
    Hist Vol33.5%(Moderate)

    Volume Flow

    VWAP$15.31
    OBV-115.6K
    AD Line-302.8K
    CMF (20d)-0.014

    Volume Metrics

    Avg Vol (20d)178.7K
    Vol Ratio1.6x(High)
    VWMA (20d)$14.63

    Pivot Points

    R3$16.16
    R2$15.72
    R1$15.34
    Pivot Point$14.89
    S1$14.51
    S2$14.07
    S3$13.69

    Advanced Oscillators

    TSI-0.62
    Ultimate Osc56.4
    KST33.65

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$223.27M$250.22M$226.20M$213.67M$235.85M$249.54M$213.61M$200.22M$212.87M$227.80M$221.08M$213.37M
    Cost of Revenue$48.34M$59.44M$49.41M$48.81M$57.93M$60.78M$42.55M$42.83M$44.15M$46.23M$45.23M$45.80M
    Gross Profit$174.93M$190.78M$176.79M$164.85M$177.92M$188.75M$171.06M$157.40M$168.72M$181.57M$175.85M$167.56M
    Operating Expenses$194.93M$176.91M$159.54M$163.63M$161.20M$173.08M$162.85M$141.79M$150.88M$156.90M$151.63M$149.96M
    R&D$0$0$0$0$0$0$11.57M$0$0$0$11.45M$0
    SG&A$82.32M$88.25M$78.08M$85.95M$81.91M$91.44M$73.35M$61.30M$60.51M$64.30M$58.66M$63.30M
    Operating Income$-19,996,000$13.87M$17.25M$1.22M$16.72M$15.67M$8.21M$15.60M$17.84M$24.67M$24.22M$17.61M
    Interest Income$595,000$437,000$495,000$578,000$619,000$723,000$2.74M$3.14M$2.76M$2.68M$2.90M$2.73M
    Interest Expense$0$240,000$123,000$49,000$259,000$411,000$129,000$49,000$51,000$52,000$145,000$43,000
    Income Before Tax$-18,900,000$15.46M$4.18M$1.79M$18.82M$16.74M$10.43M$18.61M$20.20M$27.11M$26.61M$20.53M
    Income Tax Expense$9.05M$8.51M$5.77M$8.46M$8.37M$7.45M$5.95M$8.00M$9.77M$10.57M$9.85M$9.18M
    Net Income$-21,382,000$7.51M$-1,775,000$-6,522,000$9.65M$9.40M$4.48M$10.61M$10.43M$16.54M$16.77M$11.35M
    EBITDA$-9,730,000$25.49M$14.59M$11.41M$28.68M$27.39M$16.44M$24.22M$25.96M$32.25M$31.63M$25.73M
    EBIT$-18,900,000$15.71M$4.30M$1.84M$19.08M$17.15M$10.56M$18.66M$20.25M$27.16M$26.76M$20.57M
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about USNA

    News

    USANA sets November 3 results date for USANA Health Sciences stock

    USANA Health Sciences (USNA) will release its third-quarter 2026 results after market close on November 3, 2026...

    ad-hoc-news.de•10/15/26•Somewhat-Bearish

    USANA Schedules Third Quarter 2026 Earnings Release and Conference Call

    USANA Health Sciences, Inc. (NYSE:USNA) announced that its third-quarter 2026 financial results will be released after market close on Tuesday, November 3...

    Business Wire•10/12/26•Neutral

    How Usana Health Sciences Inc. (USNA) Affects Rotational Strategy Timing

    The article analyzes Usana Health Sciences Inc. (USNA) using AI models to determine its effect on rotational strategy timing. It identifies a stable neutral reading in shorter horizons...

    Stock Traders Daily•10/10/26•Neutral

    USANA Health Sciences and University of Utah Athletics Announce New Partnership

    USANA Health Sciences and University of Utah Athletics have forged a new partnership, uniting two Utah-based organizations with a shared commitment to health, performance...

    PR Newswire•10/8/26•Bullish

    USANA Health Sciences and University of Utah Athletics Announce New Partnership

    USANA Health Sciences and University of Utah Athletics have formed a new partnership to support over 500 student-athletes across 19 sports. This collaboration will provide student-athletes with nutritional products...

    Yahoo Finance•10/7/26•Bullish

    USNA Valuation and Fair Value

    P/E
    15.6x
    Forward P/E
    7.9x
    EV/EBITDA
    2.8x
    P/FCF
    17.9x
    PEG
    0.7x
    P/B
    0.5x
    See GNG's fair value

    USNA Profitability: Margins, ROIC and FCF

    Gross margin
    77.4%
    Operating margin
    4.1%
    Net margin
    -2.4%
    ROE
    -5.1%
    FCF margin
    1.7%
    FCF yield
    5.6%

    USNA Competitors

    CompanyTicker
    SNDL Inc.SNDL
    European Wax Center IncEWCZ
    MGP Ingredients IncMGPI
    BRC Inc.BRCC
    Village Farms International IncVFF
    Nu Skin Enterprises IncNUS
    Oatly Group AB ADROTLY
    Yatsen HoldingYSG

    Sector: Consumer Defensive

    USNA Bull Case vs Bear Case

    Bull case

    • USNA beat EPS estimates in 75.0% of its last 8 reported quarters.

    Bear case

    • USNA has a -2.4% net profit margin.
    • USNA's quarterly revenue changed -5.3% year over year.

    USNA Earnings: Beat Rate and Next Report

    Beat rate
    6 of 8 quarters (75.0%)
    Average surprise
    6.9%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $0.11
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    0 up, 1 down

    Frequently Asked Questions About USNA

    Does USNA pay dividends?

    USANA Health Sciences Inc (USNA) does not currently pay a regular dividend.

    What is USNA's P/E ratio?

    USANA Health Sciences Inc has a price-to-earnings (P/E) ratio of 15.62.

    What is USNA's market cap?

    USANA Health Sciences Inc (USNA) has a market capitalization of $282.14M with a current stock price of $15.46.

    Related stocks

    Sector: Consumer Defensive

    All stocks starting with U

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In